Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models

Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are centra...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic advances in cardiovascular disease Vol. 18; p. 17539447241290438
Main Authors Ebrahimi, Reza, Rahmani, Mahdi, Fallahtafti, Parisa, Ghaseminejad-Raeini, Amirhossein, Azarboo, Alireza, Jalali, Arash, Mehrani, Mehdi
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2024
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
Online AccessGet full text
ISSN1753-9447
1753-9455
1753-9455
DOI10.1177/17539447241290438

Cover

Abstract Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. Objectives: In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Design: Systematic review. Data sources and methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. Results: The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Conclusion: Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Jargon summary Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes. Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication. Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability. Key Findings: - Search Results: Out of 7,095 citations, 16 studies were reviewed. - Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries. - Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations. - Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited. Implications: - Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice. - Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models. Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility.
AbstractList The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Systematic review. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies.
The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.BACKGROUNDThe no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.OBJECTIVESIn this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.Systematic review.DESIGNSystematic review.Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.DATA SOURCES AND METHODSPreferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.RESULTSThe three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies.CONCLUSIONClinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies.
Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. Objectives: In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Design: Systematic review. Data sources and methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. Results: The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Conclusion: Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Jargon summary Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes. Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication. Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability. Key Findings: - Search Results: Out of 7,095 citations, 16 studies were reviewed. - Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries. - Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations. - Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited. Implications: - Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice. - Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models. Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility.
Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. Objectives: In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Design: Systematic review. Data sources and methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. Results: The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Conclusion: Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Jargon summary Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes. Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication. Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability. Key Findings: - Search Results: Out of 7,095 citations, 16 studies were reviewed. - Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries. - Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations. - Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited. Implications: - Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice. - Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models. Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility.
Author Rahmani, Mahdi
Jalali, Arash
Ghaseminejad-Raeini, Amirhossein
Fallahtafti, Parisa
Azarboo, Alireza
Mehrani, Mehdi
Ebrahimi, Reza
Author_xml – sequence: 1
  givenname: Reza
  orcidid: 0009-0006-2660-6176
  surname: Ebrahimi
  fullname: Ebrahimi, Reza
  organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Mahdi
  surname: Rahmani
  fullname: Rahmani, Mahdi
  organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 3
  givenname: Parisa
  surname: Fallahtafti
  fullname: Fallahtafti, Parisa
  organization: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 4
  givenname: Amirhossein
  surname: Ghaseminejad-Raeini
  fullname: Ghaseminejad-Raeini, Amirhossein
  organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 5
  givenname: Alireza
  surname: Azarboo
  fullname: Azarboo, Alireza
  organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 6
  givenname: Arash
  surname: Jalali
  fullname: Jalali, Arash
  organization: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 7
  givenname: Mehdi
  surname: Mehrani
  fullname: Mehrani, Mehdi
  email: mehdi.mehrani78@gmail.com
  organization: Tehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran 1419733141, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39470690$$D View this record in MEDLINE/PubMed
BookMark eNp1Uk2P0zAQjdAi9gN-ABdkiQuXLHZq1zEXhFZ8rLQSSCznaGqPW1eJHeykq_42_hzOphQWxMEae-a95-fxnBcnPngsiueMXjIm5WsmxUJxLivOKkX5on5UnE25UnEhTo57Lk-L85S2lApFpXxSnGaWpEtFz4ofXyIapwfn12TYIPGhjGjbcEf6DfrQ5eWJ8-TrbYkt7mBw-dztg4ZoHLS5ZCHq-2yfi-iHREZvMK7DJNlH10Hckx6jHgfwGMZEdIjBT1nnB4y7zMn0NwRI2qcBuyyjScSdwzsSLNGt807nq_qD08lAMNimp8VjC23CZ4d4UXz78P726lN58_nj9dW7m1LzWgylRlBiZWxN1UrYWivJDQOrAaipDK25BmqrSjMLAqRCwSpBc4AMqw3HxUVxPeuaANvm8KQmgGvuEyGuG4jZdIuNolasgNe1WeYWo1ForaCGUaBcMlllrbezVj-uOjQ6Pz5C-0D0YcW7TbMOu4axJavVcpkVXh0UYvg-YhqaziWNbTt3t1mwiuV_FoJn6Mu_oNswRp97lVGCikoxNll68aelo5dfQ5IBbAboGFLK43GEMNpMg9j8M4iZczlzEqzx97X_J_wEJN_juQ
Cites_doi 10.7326/M14-0698
10.1016/S0140-6736(16)30677-8
10.1016/j.jcin.2016.11.059
10.1177/0962280218784726
10.1371/journal.pmed.1001744
10.1148/radiol.2017171920
10.1016/j.cpcardiol.2020.100676
10.1136/openhrt-2019-001215
10.1016/j.jcmg.2014.06.012
10.1093/cvr/cvz301
10.1080/14779072.2019.1653187
10.1186/s12959-023-00519-x
10.1093/eurheartj/ehq299
10.1016/j.jclinepi.2015.04.005
10.1016/j.jacc.2009.12.054
10.1111/joic.12463
10.1016/j.ihj.2018.01.032
10.1097/EDE.0b013e3181c30fb2
10.1016/j.acvd.2010.09.005
10.1016/j.jacc.2007.04.084
10.1016/j.amjms.2023.06.011
10.1016/j.jacc.2009.03.054
10.1016/j.acvd.2015.09.006
10.3389/fcvm.2022.966299
10.12659/MSM.915960
10.1007/s12265-020-10020-9
10.1007/s10554-012-0021-9
10.1016/j.jacc.2008.04.006
10.1093/eurheartj/ehp122
10.2174/1381612824666180702112536
10.1002/clc.22376
10.1093/ehjacc/zuaa004
10.1016/j.amjcard.2022.01.044
10.36468/pharmaceutical-sciences.spl.353
10.1111/eci.13686
10.1093/eurheartj/ehx393
10.1002/sim.6080
10.1186/s12916-019-1466-7
10.1016/j.atherosclerosis.2014.03.005
10.1093/ehjci/jev341
10.1007/978-0-387-77244-8
10.1177/00033197211045021
10.2147/TCRM.S353199
10.7326/M18-1377
10.1016/j.ihj.2016.04.006
10.1016/j.jclinepi.2010.11.012
10.7326/M18-1376
10.1097/MCA.0b013e32834f1b8a
10.21037/atm-20-8003
10.1136/bmj.b1793
ContentType Journal Article
Copyright The Author(s), 2024
The Author(s), 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s), 2024 2024 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s), 2024
– notice: The Author(s), 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s), 2024 2024 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1177/17539447241290438
DatabaseName Sage Journals GOLD Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Central Health & Medical Collection (via ProQuest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: AFRWT
  name: Sage Journals GOLD Open Access
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1753-9455
ExternalDocumentID oai_doaj_org_article_90f5ba488d6947ed9eff50d10a047172
PMC11618966
39470690
10_1177_17539447241290438
10.1177_17539447241290438
Genre Systematic Review
Journal Article
GroupedDBID ---
-TM
01A
0R~
123
29Q
4.4
53G
54M
5RE
5VS
7RV
7X7
8FI
8FJ
AABMB
AADUE
AAQDB
AARDL
AARIX
AASGM
ABAFQ
ABAWP
ABEIX
ABFWQ
ABJIS
ABKRH
ABQXT
ABRHV
ABUWG
ABVFX
ABXGC
ACARO
ACDSZ
ACDXX
ACGFS
ACOFE
ACROE
ACRPL
ADBBV
ADEBD
ADNMO
ADOGD
ADYCS
ADZZY
AEQLS
AERKM
AEUHG
AEWDL
AEXNY
AFCOW
AFEET
AFKRA
AFKRG
AFRWT
AFUIA
AFWMB
AGNHF
AGQPQ
AHHFK
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
B8M
BCNDV
BDDNI
BENPR
BKEYQ
BKSCU
BPHCQ
BSEHC
BVXVI
CAG
CCPQU
CDWPY
CFDXU
COF
CS3
DC-
DC.
DOPDO
EBS
EJD
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HYE
HZ~
J8X
K.F
N9A
NAPCQ
O9-
OK1
P.B
PHGZM
PHGZT
PIMPY
PQQKQ
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PPXIY
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c485t-cea95bdf809b5f8c974d1afcaa0d2d084ca0f22c1fa5a79e512509e5a4d18d4e3
IEDL.DBID 7X7
ISSN 1753-9447
1753-9455
IngestDate Wed Aug 27 01:21:46 EDT 2025
Thu Aug 21 18:34:58 EDT 2025
Thu Sep 04 22:30:17 EDT 2025
Fri Jul 25 21:05:20 EDT 2025
Mon Jul 21 05:55:29 EDT 2025
Tue Jul 01 05:28:17 EDT 2025
Tue Jun 17 22:26:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords STEMI
percutaneous coronary intervention
prediction model
systematic review
no-reflow phenomenon
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-cea95bdf809b5f8c974d1afcaa0d2d084ca0f22c1fa5a79e512509e5a4d18d4e3
Notes ObjectType-Article-1
ObjectType-Evidence Based Healthcare-3
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0009-0006-2660-6176
OpenAccessLink https://www.proquest.com/docview/3150529112?pq-origsite=%requestingapplication%
PMID 39470690
PQID 3150529112
PQPubID 4450850
ParticipantIDs doaj_primary_oai_doaj_org_article_90f5ba488d6947ed9eff50d10a047172
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11618966
proquest_miscellaneous_3121590554
proquest_journals_3150529112
pubmed_primary_39470690
crossref_primary_10_1177_17539447241290438
sage_journals_10_1177_17539447241290438
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: Thousand Oaks
– name: Sage UK: London, England
PublicationTitle Therapeutic advances in cardiovascular disease
PublicationTitleAlternate Ther Adv Cardiovasc Dis
PublicationYear 2024
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
– name: SAGE Publishing
References Wolff, Moons, Riley 2019; 170
Moons, de Groot, Bouwmeester 2014; 11
Stajic, Milicevic, Kafedzic 2022; 26
Kumar, Ammar, Saghir 2022; 171
Moons, Altman, Reitsma 2015; 162
Scarpone, Cenko, Manfrini 2018; 24
Tanaka, Imanishi, Kitabata 2009; 30
Reed, Rossi, Cannon 2017; 389
Steyerberg, Harrell 2016; 69
Dai, Liu, Zhou 2022; 52
Wong, Leung, Richardson 2012; 28
Xiao, Fu, Wang 2019; 25
Kennedy, Kim, Martin 2023; 366
Douglas, Yvonne, Patrick 2009; 338
Gür, Türkoǧlu, Taşkin 2014; 234
Uyarel, Ayhan, Cicek 2012; 23
Bouleti, Mewton, Germain 2015; 108
Boden, Eagle, Granger 2007; 50
Hamirani, Wong, Kramer 2014; 7
van Smeden, Moons, de Groot 2019; 28
Gupta, Gupta 2016; 68
Kumar, O’Connor, Kumar 2019; 17
Van Calster, McLernon, van Smeden 2019; 17
Niccoli, Burzotta, Galiuto 2009; 54
Ndrepepa, Tiroch, Fusaro 2010; 55
Zhang, Ji, Du 2021; 83
Debray, Koffijberg, Nieboer 2014; 33
Nijveldt, Beek, Hirsch 2008; 52
Amabile, Jacquier, Gaudart 2010; 103
Xu, Song, Xu 2021; 46
Fajar, Heriansyah, Rohman 2018; 70
Liu, Ye, Chen 2022; 9
Steyerberg, Vickers, Cook 2010; 21
Yang, Cong, Lu 2020; 99
Rezkalla, Stankowski, Hanna 2017; 10
Rossington, Sol, Masoura 2020; 7
Wang, Chen, Wang 2013; 124
Liu, Wang, Wang 2022; 18
Dogan, Ozpelit, Akdeniz 2015; 31
Hahn, Jeon, Geum 2023; 21
Ibanez, James, Agewall 2017; 39
Salama, Khalil, Al-Zaky 2020; 13
Park, Han 2018; 286
Moons, Wolff, Riley 2019; 170
Konijnenberg, Damman, Duncker 2020; 116
Yang, Cong, Lu 2021; 9
Courvoisier, Combescure, Agoritsas 2011; 64
Richard, Joie, Kym 2020; 368
Ozkalayci, Turkyilmaz, Karagoz 2022; 73
Bayramoğlu, Taşolar, Kaya 2018; 31
Wang, Zhou, Chen 2015; 38
Niccoli, Kharbanda, Crea 2010; 31
Russo, Montone, D’amario 2021; 10
Soeda, Higuma, Abe 2017; 18
bibr11-17539447241290438
bibr24-17539447241290438
bibr37-17539447241290438
Dogan NB (bibr29-17539447241290438) 2015; 31
bibr17-17539447241290438
bibr1-17539447241290438
bibr44-17539447241290438
bibr31-17539447241290438
bibr7-17539447241290438
bibr49-17539447241290438
bibr36-17539447241290438
bibr16-17539447241290438
bibr6-17539447241290438
bibr10-17539447241290438
Douglas GA (bibr51-17539447241290438) 2009; 338
Stajic Z (bibr20-17539447241290438) 2022; 26
bibr18-17539447241290438
bibr2-17539447241290438
bibr53-17539447241290438
bibr43-17539447241290438
bibr32-17539447241290438
bibr42-17539447241290438
bibr22-17539447241290438
bibr12-17539447241290438
bibr28-17539447241290438
bibr52-17539447241290438
bibr8-17539447241290438
bibr38-17539447241290438
bibr47-17539447241290438
bibr34-17539447241290438
bibr9-17539447241290438
bibr41-17539447241290438
bibr54-17539447241290438
bibr14-17539447241290438
bibr21-17539447241290438
bibr4-17539447241290438
bibr39-17539447241290438
bibr13-17539447241290438
bibr3-17539447241290438
bibr19-17539447241290438
bibr26-17539447241290438
bibr33-17539447241290438
Richard DR (bibr48-17539447241290438) 2020; 368
bibr40-17539447241290438
bibr5-17539447241290438
bibr30-17539447241290438
bibr50-17539447241290438
Yang L (bibr27-17539447241290438) 2020; 99
bibr46-17539447241290438
bibr55-17539447241290438
bibr25-17539447241290438
Wang J-W (bibr23-17539447241290438) 2013; 124
bibr15-17539447241290438
bibr35-17539447241290438
bibr45-17539447241290438
References_xml – volume: 30
  start-page: 1348
  year: 2009
  end-page: 1355
  article-title: Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study
  publication-title: Eur Heart J
– volume: 7
  year: 2020
  article-title: No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case-control study (NORM PPCI)
  publication-title: Open Heart
– volume: 368
  year: 2020
  article-title: Calculating the sample size required for developing a clinical prediction model
  publication-title: BMJ
– volume: 38
  start-page: 208
  year: 2015
  end-page: 215
  article-title: A risk score for no reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
  publication-title: Clin Cardiol
– volume: 46
  start-page: 100676
  year: 2021
  article-title: A scoring system to predict no-reflow phenomenon in elective percutaneous coronary intervention: the RECOVER Score
  publication-title: Current Problems Cardiol
– volume: 54
  start-page: 281
  year: 2009
  end-page: 292
  article-title: Myocardial no-reflow in humans
  publication-title: J Am Coll Cardiol
– volume: 11
  year: 2014
  article-title: Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist
  publication-title: PLoS Med
– volume: 25
  start-page: 5864
  year: 2019
  end-page: 5877
  article-title: Development and validation of risk nomogram model predicting coronary microvascular obstruction in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous catheterization
  publication-title: Medical Sci Monitor
– volume: 234
  start-page: 415
  year: 2014
  end-page: 420
  article-title: Paraoxonase–1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow
  publication-title: Atherosclerosis
– volume: 26
  start-page: 759
  year: 2022
  end-page: 770
  article-title: Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 69
  start-page: 245
  year: 2016
  end-page: 247
  article-title: Prediction models need appropriate internal, internal-external, and external validation
  publication-title: J Clin Epidemiol
– volume: 21
  start-page: 76
  year: 2023
  article-title: Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
  publication-title: Thromb J
– volume: 17
  start-page: 230
  year: 2019
  article-title: Calibration: the Achilles heel of predictive analytics
  publication-title: BMC Medicine
– volume: 99
  year: 2020
  article-title: Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
  publication-title: Medicine (United States)
– volume: 116
  start-page: 787
  year: 2020
  end-page: 805
  article-title: Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction
  publication-title: Cardiovasc Res
– volume: 103
  start-page: 512
  year: 2010
  end-page: 521
  article-title: Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention
  publication-title: Arch Cardiovascular Dis
– volume: 55
  start-page: 2383
  year: 2010
  end-page: 2389
  article-title: 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
  publication-title: J Am Coll Cardiol
– volume: 389
  start-page: 197
  year: 2017
  end-page: 210
  article-title: Acute myocardial infarction
  publication-title: Lancet
– volume: 64
  start-page: 993
  year: 2011
  end-page: 1000
  article-title: Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure
  publication-title: J Clin Epidemiol
– volume: 31
  start-page: 2449
  year: 2010
  end-page: 2455
  article-title: No-reflow: again prevention is better than treatment
  publication-title: Eur Heart J
– volume: 23
  start-page: 98
  year: 2012
  end-page: 104
  article-title: Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis
  publication-title: Coronary Artery Dis
– volume: 366
  start-page: 227
  year: 2023
  end-page: 235
  article-title: Total ischemic time and age as predictors of PCI failure in STEMIs: a systematic review
  publication-title: Am J Medical Sci
– volume: 39
  start-page: 119
  year: 2017
  end-page: 177
  article-title: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
  publication-title: European Heart J
– volume: 70
  year: 2018
  article-title: The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis
  publication-title: Indian Heart J
– volume: 18
  start-page: 155
  year: 2022
  end-page: 169
  article-title: Development and validation of a clinical and laboratory-based nomogram for predicting coronary microvascular obstruction in NSTEMI patients after primary PCI
  publication-title: Ther Clin Risk Manage
– volume: 10
  start-page: 633
  year: 2021
  end-page: 642
  article-title: Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction
  publication-title: Eur Heart J: Acute Cardiovasc Care
– volume: 108
  start-page: 661
  year: 2015
  end-page: 674
  article-title: The no-reflow phenomenon: state of the art
  publication-title: Arch Cardiovasc Dis
– volume: 21
  start-page: 128
  year: 2010
  end-page: 138
  article-title: Assessing the performance of prediction models: a framework for traditional and novel measures
  publication-title: Epidemiology
– volume: 52
  year: 2022
  article-title: A score system to predict no-reflow in primary percutaneous coronary intervention: the PIANO Score
  publication-title: Eur J Clin Invest
– volume: 170
  year: 2019
  article-title: PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration
  publication-title: Ann Intern Med
– volume: 52
  start-page: 181
  year: 2008
  end-page: 189
  article-title: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury
  publication-title: J Am Coll Cardiol
– volume: 24
  start-page: 2927
  year: 2018
  end-page: 2933
  article-title: Coronary no-reflow phenomenon in clinical practice
  publication-title: Curr Pharm Des
– volume: 31
  start-page: 144
  year: 2018
  end-page: 149
  article-title: Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients
  publication-title: J Interventional Cardiol
– volume: 9
  start-page: 126
  year: 2021
  article-title: A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction
  publication-title: Annal Transl Med
– volume: 170
  start-page: 51
  year: 2019
  end-page: 58
  article-title: PROBAST: a tool to assess the risk of bias and applicability of prediction model studies
  publication-title: Ann Intern Med
– volume: 68
  start-page: 539
  year: 2016
  end-page: 551
  article-title: No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
  publication-title: Indian Heart J
– volume: 286
  start-page: 800
  year: 2018
  end-page: 809
  article-title: Methodologic guide for evaluating clinical performance and effect of artificial intelligence technology for medical diagnosis and prediction
  publication-title: Radiology
– volume: 33
  start-page: 2341
  year: 2014
  end-page: 2362
  article-title: Meta-analysis and aggregation of multiple published prediction models
  publication-title: Stat Med
– volume: 10
  start-page: 215
  year: 2017
  end-page: 223
  article-title: Management of no-reflow phenomenon in the catheterization laboratory
  publication-title: JACC: Cardiovas Interventions
– volume: 17
  start-page: 605
  year: 2019
  end-page: 623
  article-title: Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management
  publication-title: Expert Rev Cardiovasc Ther
– volume: 124
  start-page: 153
  year: 2013
  end-page: 160
  article-title: Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
  publication-title: Cardiology (Switzerland)
– volume: 162
  year: 2015
  article-title: Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration
  publication-title: Ann Intern Med
– volume: 9
  start-page: 966299
  year: 2022
  article-title: A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis
  publication-title: Front Cardiovasc Med
– volume: 28
  start-page: 2455
  year: 2019
  end-page: 2474
  article-title: Sample size for binary logistic prediction models: beyond events per variable criteria
  publication-title: Stat Methods Med Res
– volume: 7
  start-page: 940
  year: 2014
  end-page: 952
  article-title: Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis
  publication-title: JACC Cardiovasc Imaging
– volume: 31
  start-page: 576
  year: 2015
  end-page: 581
  article-title: Simple clinical risk score for no-reflow prediction in patients undergoing primary percutaneous coronary intervention with acute STEMI
  publication-title: Pakistan J Med Sci
– volume: 50
  start-page: 917
  year: 2007
  end-page: 929
  article-title: Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options
  publication-title: J Am College Cardiol
– volume: 171
  start-page: 32
  year: 2022
  end-page: 39
  article-title: Development and validation of a novel risk stratification model for slow-flow/no-reflow during primary percutaneous coronary intervention (the RK-SF/NR Score)
  publication-title: Am J Cardiol
– volume: 83
  start-page: 217
  year: 2021
  end-page: 223
  article-title: Establishment and evaluation of nomogram model for predicting the risk of no reflow after percutaneous coronary intervention in patients with acute myocardial infarction
  publication-title: Indian J Pharm Sci
– volume: 13
  start-page: 988
  year: 2020
  end-page: 995
  article-title: MicroRNA–208a: a good diagnostic marker and a predictor of no-reflow in STEMI patients undergoing primary percutaneuos coronary intervention
  publication-title: J Cardiovasc Transl Res
– volume: 73
  start-page: 365
  year: 2022
  end-page: 373
  article-title: A clinical score to predict “corrected thrombolysis in myocardial infarction frame count” in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
  publication-title: Angiology
– volume: 338
  year: 2009
  article-title: Prognosis and prognostic research: validating a prognostic model
  publication-title: BMJ
– volume: 28
  start-page: 1971
  year: 2012
  end-page: 1981
  article-title: Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements
  publication-title: Int J Cardiovasc Imaging
– volume: 18
  start-page: 103
  year: 2017
  end-page: 110
  article-title: Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture
  publication-title: Eur Heart J Cardiovascular Imaging
– ident: bibr15-17539447241290438
  doi: 10.7326/M14-0698
– ident: bibr1-17539447241290438
  doi: 10.1016/S0140-6736(16)30677-8
– ident: bibr12-17539447241290438
  doi: 10.1016/j.jcin.2016.11.059
– volume: 31
  start-page: 576
  year: 2015
  ident: bibr29-17539447241290438
  publication-title: Pakistan J Med Sci
– ident: bibr49-17539447241290438
  doi: 10.1177/0962280218784726
– ident: bibr13-17539447241290438
  doi: 10.1371/journal.pmed.1001744
– ident: bibr52-17539447241290438
  doi: 10.1148/radiol.2017171920
– ident: bibr41-17539447241290438
  doi: 10.1016/j.cpcardiol.2020.100676
– ident: bibr31-17539447241290438
  doi: 10.1136/openhrt-2019-001215
– ident: bibr45-17539447241290438
  doi: 10.1016/j.jcmg.2014.06.012
– ident: bibr43-17539447241290438
  doi: 10.1093/cvr/cvz301
– ident: bibr10-17539447241290438
  doi: 10.1080/14779072.2019.1653187
– ident: bibr3-17539447241290438
  doi: 10.1186/s12959-023-00519-x
– ident: bibr11-17539447241290438
  doi: 10.1093/eurheartj/ehq299
– ident: bibr53-17539447241290438
  doi: 10.1016/j.jclinepi.2015.04.005
– ident: bibr8-17539447241290438
  doi: 10.1016/j.jacc.2009.12.054
– ident: bibr28-17539447241290438
  doi: 10.1111/joic.12463
– ident: bibr33-17539447241290438
  doi: 10.1016/j.ihj.2018.01.032
– ident: bibr46-17539447241290438
  doi: 10.1097/EDE.0b013e3181c30fb2
– volume: 124
  start-page: 153
  year: 2013
  ident: bibr23-17539447241290438
  publication-title: Cardiology (Switzerland)
– ident: bibr30-17539447241290438
  doi: 10.1016/j.acvd.2010.09.005
– ident: bibr4-17539447241290438
  doi: 10.1016/j.jacc.2007.04.084
– ident: bibr32-17539447241290438
  doi: 10.1016/j.amjms.2023.06.011
– ident: bibr9-17539447241290438
  doi: 10.1016/j.jacc.2009.03.054
– ident: bibr6-17539447241290438
  doi: 10.1016/j.acvd.2015.09.006
– ident: bibr21-17539447241290438
  doi: 10.3389/fcvm.2022.966299
– ident: bibr25-17539447241290438
  doi: 10.12659/MSM.915960
– ident: bibr37-17539447241290438
  doi: 10.1007/s12265-020-10020-9
– ident: bibr42-17539447241290438
  doi: 10.1007/s10554-012-0021-9
– ident: bibr44-17539447241290438
  doi: 10.1016/j.jacc.2008.04.006
– ident: bibr36-17539447241290438
  doi: 10.1093/eurheartj/ehp122
– ident: bibr7-17539447241290438
  doi: 10.2174/1381612824666180702112536
– volume: 26
  start-page: 759
  year: 2022
  ident: bibr20-17539447241290438
  publication-title: Eur Rev Med Pharmacol Sci
– ident: bibr22-17539447241290438
  doi: 10.1002/clc.22376
– ident: bibr38-17539447241290438
  doi: 10.1093/ehjacc/zuaa004
– ident: bibr19-17539447241290438
  doi: 10.1016/j.amjcard.2022.01.044
– ident: bibr26-17539447241290438
  doi: 10.36468/pharmaceutical-sciences.spl.353
– volume: 368
  year: 2020
  ident: bibr48-17539447241290438
  publication-title: BMJ
– ident: bibr17-17539447241290438
  doi: 10.1111/eci.13686
– ident: bibr2-17539447241290438
  doi: 10.1093/eurheartj/ehx393
– ident: bibr54-17539447241290438
  doi: 10.1002/sim.6080
– ident: bibr47-17539447241290438
  doi: 10.1186/s12916-019-1466-7
– ident: bibr39-17539447241290438
  doi: 10.1016/j.atherosclerosis.2014.03.005
– ident: bibr35-17539447241290438
  doi: 10.1093/ehjci/jev341
– ident: bibr55-17539447241290438
  doi: 10.1007/978-0-387-77244-8
– ident: bibr18-17539447241290438
  doi: 10.1177/00033197211045021
– ident: bibr40-17539447241290438
  doi: 10.2147/TCRM.S353199
– ident: bibr34-17539447241290438
  doi: 10.7326/M18-1377
– ident: bibr5-17539447241290438
  doi: 10.1016/j.ihj.2016.04.006
– ident: bibr50-17539447241290438
  doi: 10.1016/j.jclinepi.2010.11.012
– ident: bibr14-17539447241290438
  doi: 10.7326/M18-1376
– ident: bibr16-17539447241290438
  doi: 10.1097/MCA.0b013e32834f1b8a
– volume: 99
  year: 2020
  ident: bibr27-17539447241290438
  publication-title: Medicine (United States)
– ident: bibr24-17539447241290438
  doi: 10.21037/atm-20-8003
– volume: 338
  year: 2009
  ident: bibr51-17539447241290438
  publication-title: BMJ
  doi: 10.1136/bmj.b1793
SSID ssj0059077
Score 2.3037236
SecondaryResourceType review_article
Snippet Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients...
The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment...
Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 17539447241290438
SubjectTerms Age Factors
Angioplasty
Cardiovascular disease
Clinical Decision Rules
Clinical Decision-Making - methods
Content analysis
Coronary Circulation
Decision Support Techniques
Heart attacks
Humans
Ischemia
No-Reflow Phenomenon - diagnosis
No-Reflow Phenomenon - etiology
No-Reflow Phenomenon - physiopathology
Percutaneous Coronary Intervention - adverse effects
Predictive Value of Tests
Reproducibility of Results
Risk Assessment
Risk Factors
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - physiopathology
ST Elevation Myocardial Infarction - therapy
Systematic Review
Thrombolytic drugs
Time Factors
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFD5IH8QX8e5olQiCIAQzM8nMxDcVSxEqgi30bcjkogvtTNkL0t_WP-c5SXa7SxVffFuSkD2TfJl8Z3LyHYDXTRfQ0RhaLmsvOfobNR_KRvDWORlso2sTv0MefW0OT-SXU3W6leqLYsKSPHAauHdaBDUYhJlrtGy90z4EJVwpsBN0ReLbV2ixdqbSO1ihy9fmM0ySVyI5Si1li9tVpensa2cXimL9f2KYNwMlt6K94gZ0cA_uZubIPiSL78MtPz6A20f5bPwhXH2b028KY2bI6tg4cfzfs-kXozAuElqYRjYb2fdjTnfK44yw80vcywgjZ1gVEPSxNIutLhjdMJv_mKjLiyRLwS783K6QUfpptWCW9A-odLYVOvmeGXYtEM3S5Rg2Bba-hYl9JUvJAMrEs3gEJwefjz8d8pyagVvZqSW33mg1uNAJPajQWfRKXGmCNUa4yolOWiNCVdkyGGVa7ZFWIDPxymCzzklfP4Y9fGr_FJiwspTIYyqD3MwrZapOWUOy8wG5kQ8FvF1PVZ8ftS-zSPmNeS3gI03mpiGJZ8cChFSfIdX_C1IF7K-h0OcVvejrklL-4daA1a821bgW6YAlDTq2QQKlBTK0Ap4k5GwsQTtbUoUuoNvB1I6puzXj7GfU-y4pqQG6pQW8Ifhd2_TXYXj2P4bhOdypkMGl7037sLecr_wLZGDL4WVcbL8BITswQw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Sage Journals GOLD Open Access
  dbid: AFRWT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3batwwEBVpAqUvJb27SYsKhUJBjWxLtpWXkpYuoZBS2g3Nm5F1SReydvCuCfm2_FxmbHmTJSn0zUjCGksz1pFmdIaQ91nhYaNR5UykTjDYb6SsijPOcmuFN5lKdX8OefQjOzwW30_kyQZpxrswYQQXnzCsCiTqf9Zo3XgavRecjHtIL6mEyGH5SRT6sj53y3k5HHePWTWwBP3T3Rxd2wYDIi_ZeL3tAdlC6nIwia2Dya8_0_HnLWGv2OdjgQ4Y9hAcofd2uraU9Yz_98HUu9GWt0LG-lVssk0eB_hJDwZ9eUI2XP2UPDwKDvZn5Opni88YC00BGtK6YdDvWXNBMRYM2Rqams5q-nvK8GJ6P610fgkLIiraGVR5sJy-NDC2LiheU2tPG3zl-cBtQc9dazqApa7pFtQgiQKWzm7FX-5TTW9Ypulww4Y2no5XOeFdg6QoAKbzWTwnx5Nv06-HLOR3YEYUcsmM00pW1hdcVdIXBrY2NtbeaM1tYnkhjOY-SUzstdS5coBNAN44qaFZYYVLX5BN-Gr3ilBuRCwADCUaAJ6TUieFNBq56z0ALOcj8nGcqjJ8ahkHpvM78xqRLziZq4bIwN0XNO1pGQy6VNzLSsPvz2ZK5M4q573kNuag3LBFTiKyO6pCOSp1mcaYNxDWF6h-t6oGg0YvzTDo0AZQmOIA8yLyctCclSQgZ47U0hEp1nRqTdT1mnr2tycNjzEzAuxtI_IB1e9Gpn8Ow-v_brlDHiWA9YaTqV2yuWw79waw2rJ6G-zrGlKjPYM
  priority: 102
  providerName: SAGE Publications
Title Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models
URI https://journals.sagepub.com/doi/full/10.1177/17539447241290438
https://www.ncbi.nlm.nih.gov/pubmed/39470690
https://www.proquest.com/docview/3150529112
https://www.proquest.com/docview/3121590554
https://pubmed.ncbi.nlm.nih.gov/PMC11618966
https://doaj.org/article/90f5ba488d6947ed9eff50d10a047172
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9swEBZbC2Nfxt7nrgsaDAYDMb9ItrUvox0NZdBSupTlm5H10gY6O7MTyn7b_tzuZCVp6LZPMZJwTtad9Jx0eo6Qd3npwNGoC8Yzyxn4GxmrkzxmhTHc6Vxmyu9Dnpzmxxf861RMw4ZbH8IqV3Oin6hNq3GP_GOWYMo1MM308_wnw6xReLoaUmjcJ7sJIBFM3VBM1w6XAMfPJ1cBSM4k50U41UTCJSzDIljAUomnYVvrkqfv_xvmvBs6eSv-yy9J48fkUcCS9GAY_Cfknm2ekgcn4bT8Gfl91uEzBjZTwHm0aRn873V7QzGwC6kX2obOGvptwvCWuR8j-uMXrG6oNddQ5cAMfGmgX-0p3jnrLlt85XwgqqBz2-klYEzbLnuqkREBS2e3gik_UUU3lNF0uC5DW0dX9zLhXYOkKADm5umfk4vx0eTLMQvJGpjmpVgwbZUUtXFlLGvhSg1-ikmU00rFJjVxybWKXZrqxCmhCmkBaABWsUJBs9Jwm70gO9Br-4rQWPOEA7JJFaA1K4RKS6EVEtE7QEvWReTDaqiq0NUqCbTld8Y1Ioc4mOuGSKftC9rusgrWWcnYiVrBXGZyyQtrpHVOxCaJQVPB300jsr9ShSrYeF9tNDIib9fVYJ145DJ8dGgDkErGgNki8nLQnLUkIGeBPNERKbd0akvU7ZpmduUZwBNMcwCOakTeo_ptZPrnZ9j7fw9ek4cpoLVhb2mf7Cy6pX0DaGtRj7xJjcjuwfj8-wR-D49Oz85Hfu_iD-uELfE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwED-NToJ9QbwJDDASCAnJIkntJkGaEINNHVurCTpp34Ljx1ZpNKUPTfvbkPjbuEucdtWAb_tWOZZ7ts_3sO9-B_Cqkzp0NIqEi7YVHP2NNi-iTsgTY4TTnaytqnvIXr_TPRJfjuXxGvxucmEorLKRiZWgNqWmO_J37YhKruHRjD-Mf3KqGkWvq00JDeVLK5itCmLMJ3bs24tzdOGmW3ufcb9fx_HuzuBTl_sqA1yLVM64tiqThXFpmBXSpRoNbBMpp5UKTWzCVGgVujjWkVNSJZlFDYlK1kqF3VIjbBvHvQHrgi5QWrC-vdM__NroAomuZ1XeBZ0CngmR-HdVgnyiNmpCFRpn9B63ohmrAgJ_s3qvBm9eikCrlOLuHbjtrVn2sWa_u7BmR_fgZs-_19-HX4cT-k2h1QwtTTYqOf7vWXnOKLSMwB_KERuO2LcBpzz3ikvYjwvUr8S3Z_jJ4QpXrR4Adsoo621yUtKQ4xoqg43tRM_RyrXlfMo0YTJQ6_BSOOd7ptgStJrVCTusdKzJDMWxakqJAKoONH0AR9eykQ-hhbO2j4GFWkQCbatYob1opVRxKrUiKHyH9pp1Abxttir3U80jD5x-ZV8D2KbNXHQkQO-qoZyc5F4-5FnoZKFQmppOJhJrMuucDE0U4llBjzsOYLNhhdxLmWm-PBMBvFx8RvlAjz71omMfNOqyEK3GAB7VnLOgBOlMCKk6gHSFp1ZIXf0yGp5WGOQRFVpAVzmAN8R-S5r-uQxP_j-DF3CrO-gd5Ad7_f2nsBGj7VjfdG1CazaZ22do-82K5_6AMfh-3Wf6DyHabzE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3bbtQwEB3BVqp4QdwJFDASEhKSqZPYm4S3clmVS6sKtqJvkeNLWakkq-yuEN_GzzGTONuuWiTeIttxJvbYPuMZHwO8GOceDY0q4zJ1kqO9kfIqHgueWSu9GRep7vYhDw7H-8fy04k6CRtudBYmtODiNYVVoUTdZE2je279bvAx7hK7ZCFlhqtPUpAr6zps4WdyMYKtvcnX79NhLlZo-nXXq-ALnN4Ifs0rK9lYmToC_6tQ5-XgyQsRYN2iNLkFNwOaZHt999-Ga66-A9sHwV9-F_4ctfRMoc0MkR6rG47fPWt-MQrtIvKFpmazmn2bcjpn3vUS-_kb1zfSmzPM8jgQutRAwLpgdOqsPW2oynlPVcHmrjUrRJmuWS2YIU4ESp1dCKd8wzQ7J41m_YEZ1ng2nMzEunpJSQC6nWdxD44nH6bv9nm4roEbmaslN04XqrI-F0WlfG7QUrGx9kZrYRMrcmm08EliYq-VzgqHUAPRilMai-VWuvQ-jPCv3UNgwshYIrZJNOI1p5ROcmU0UdF7xEvOR_Bq6Koy_GoZB-LyS_0awVvqzHVBItTuEpr2tAzjsyyEV5XG2cyOC5k5WzjvlbCxQF1FizeJYGdQhXLQ0TKN6RpAXC4w-_k6G8cnOV36RscyCKoKgagtgge95qwlQTkzYoqOIN_QqQ1RN3Pq2Y-OAzymiw7QVI3gJanfuUz_bIZH_13yGWwfvZ-UXz4efn4MNxJEcf2e0w6Mlu3KPUEUtqyehqH2FzojLAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+the+no-reflow+phenomenon+in+ST-elevation+myocardial+infarction+patients+undergoing+primary+percutaneous+coronary+intervention%3A+a+systematic+review+of+clinical+prediction+models&rft.jtitle=Therapeutic+advances+in+cardiovascular+disease&rft.au=Ebrahimi%2C+Reza&rft.au=Rahmani%2C+Mahdi&rft.au=Fallahtafti%2C+Parisa&rft.au=Ghaseminejad-Raeini%2C+Amirhossein&rft.date=2024-01-01&rft.issn=1753-9455&rft.eissn=1753-9455&rft.volume=18&rft.spage=17539447241290438&rft_id=info:doi/10.1177%2F17539447241290438&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1753-9447&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1753-9447&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1753-9447&client=summon